Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Immunotherapy can help treat severe alopecia areata.

Pimecrolimus cream is not effective for treating alopecia areata.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.